Clinical trial
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
NCT00624078 is registered in ClinicalTrials.gov with Instituto Bioclon S.A. de C.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
- Lead sponsor
- Instituto Bioclon S.A. de C.V.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- September 30, 2010
- Enrollment
- 1,426 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
scorpion sting envenomation